Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Distler

Showing results (31-40 of 350) with videos related to

Pageof 35
Sort By:
Zeitschrift Fur Geburtshilfe Und Neonatologie|December 19, 1998
[Fetal acidemia and neonatal encephalopathy]A Riehn, C Petzold, E Kuhlisch, et al.
Vascular Pharmacology|December 13, 2012
The Fra-2 transgenic mouse model of systemic sclerosisBritta Maurer, Jörg H W Distler, Oliver Distler
Current Opinion in Pharmacology|June 11, 2013
Treating skin and lung fibrosis in systemic sclerosis: a future filled with promise?Milos Antic, Jörg H W Distler, Oliver Distler
Archives of Gynecology|January 1, 1985
The value of ovarian and placental steroid determinations in abnormal early pregnancyW Distler, P Hüsgen, P Kozlowski, et al.
Rheumatology (Oxford, England)|September 22, 2006
Angiogenesis and vasculogenesis in systemic sclerosisJ H W Distler, S Gay, O Distler
Current Rheumatology Reports|November 3, 2010
Tyrosine kinase inhibitors in the treatment of systemic sclerosis: from animal models to clinical trialsNaoki Iwamoto, Jörg H W Distler, Oliver Distler
Current Opinion in Rheumatology|March 28, 2012
Innovative antifibrotic therapies in systemic sclerosisChristian Beyer, Oliver Distler, Jörg H W Distler
Swiss Medical Weekly|April 27, 2010
Are tyrosine kinase inhibitors promising for the treatment of systemic sclerosis and other fibrotic diseases?Christian Beyer, Jörg H W Distler, Oliver Distler
Geburtshilfe Und Frauenheilkunde|April 1, 1986
[Puberty and ovarian function following cytostatic therapy in childhood]W Distler, H Kuhrke, H Jürgens, et al.
Experimental Dermatology|January 31, 2014
Deciphering the pro-fibrotic phenotype of fibroblasts in systemic sclerosisChristiane Maier, Jörg H W Distler, Christian Beyer
Pageof 35

Showing results (31-40 of 350) with videos related to

Sort By:
Pageof 35
Zeitschrift Fur Geburtshilfe Und Neonatologie|December 19, 1998
[Fetal acidemia and neonatal encephalopathy]A Riehn, C Petzold, E Kuhlisch, et al.
Vascular Pharmacology|December 13, 2012
The Fra-2 transgenic mouse model of systemic sclerosisBritta Maurer, Jörg H W Distler, Oliver Distler
Current Opinion in Pharmacology|June 11, 2013
Treating skin and lung fibrosis in systemic sclerosis: a future filled with promise?Milos Antic, Jörg H W Distler, Oliver Distler
Archives of Gynecology|January 1, 1985
The value of ovarian and placental steroid determinations in abnormal early pregnancyW Distler, P Hüsgen, P Kozlowski, et al.
Rheumatology (Oxford, England)|September 22, 2006
Angiogenesis and vasculogenesis in systemic sclerosisJ H W Distler, S Gay, O Distler
Current Rheumatology Reports|November 3, 2010
Tyrosine kinase inhibitors in the treatment of systemic sclerosis: from animal models to clinical trialsNaoki Iwamoto, Jörg H W Distler, Oliver Distler
Current Opinion in Rheumatology|March 28, 2012
Innovative antifibrotic therapies in systemic sclerosisChristian Beyer, Oliver Distler, Jörg H W Distler
Swiss Medical Weekly|April 27, 2010
Are tyrosine kinase inhibitors promising for the treatment of systemic sclerosis and other fibrotic diseases?Christian Beyer, Jörg H W Distler, Oliver Distler
Geburtshilfe Und Frauenheilkunde|April 1, 1986
[Puberty and ovarian function following cytostatic therapy in childhood]W Distler, H Kuhrke, H Jürgens, et al.
Experimental Dermatology|January 31, 2014
Deciphering the pro-fibrotic phenotype of fibroblasts in systemic sclerosisChristiane Maier, Jörg H W Distler, Christian Beyer
Pageof 35